New drug trial aims to free blood cancer patients from frequent transfusions
NCT ID NCT05732961
Summary
This study is testing whether the drug luspatercept can help adults with certain lower-risk blood disorders (MDS or MDS/MPN) who have anemia and require regular blood transfusions. Participants will receive luspatercept along with standard supportive care to see if it reduces their need for transfusions. The research will also monitor the drug's safety and how well it's tolerated by patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.